Skip to contentHASSAN FRED — SCHERING PLOUGH CORP insider: 196 transactions · InsiderLensHASSAN FRED
- Director at BIOZONE PHARMACEUTICALS, INC. · on record since Apr 27, 2023
- Director at SCHERING PLOUGH CORP · on record since May 23, 2006
- Chairman and CEO at SCHERING PLOUGH CORP · on record since May 23, 2006
- Director at AVON PRODUCTS INC · on record since May 8, 2006
- Director at PRECIGEN, INC. · on record since Jul 13, 2016
- Director at pSivida LTD · on record since Sep 5, 2024
- Director at TIME WARNER INC · on record since Oct 30, 2009
- Director at ELECTRONIC DATA SYSTEMS CORP /DE/ · on record since Oct 29, 2003
- Director at Ignyta, Inc. · on record since May 17, 2021
- Director at VALEANT PHARMACEUTICALS INTERNATIONAL · on record since Aug 23, 2013
- Director at AMGEN INC · on record since Jul 30, 2015
- Director at BridgeBio Pharma, Inc. · on record since Aug 26, 2021
Insider trading activity of HASSAN FRED
- Transactions on record
- 196
- since Dec 1, 2003
- Open-market buys
- 27
- $10M
- Open-market sells
- 0
- Companies traded
- 10
- last filing Jun 24, 2026
Figures computed from official regulatory filings — methodology.
Companies where HASSAN FRED has traded
- BridgeBio Pharma, Inc.9 tx · $273.5K · Jun 24, 2026
- PRECIGEN, INC.49 tx · $1.7M · Mar 16, 2026
- BIOZONE PHARMACEUTICALS, INC.5 tx · $1.5M · Jan 13, 2026
- pSivida LTD3 tx · Jan 6, 2026
- Ignyta, Inc.8 tx · Jun 16, 2023
- AMGEN INC8 tx · $501.6K · May 7, 2020
- TIME WARNER INC48 tx · $1M · Jun 18, 2018
- VALEANT PHARMACEUTICALS INTERNATIONAL2 tx · $5M · Sep 3, 2013
- AVON PRODUCTS INC15 tx · $325.4K · May 7, 2012
- SCHERING PLOUGH CORP
Track record of HASSAN FRED
Statistical track record
Free- Open-market buys
- 27
- Last buy
- Aug 14, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of HASSAN FRED
Co-insiders of HASSAN FRED
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
49 tx · $11.4M · Nov 4, 2009
Stolz Brian M.BridgeBio Pharma, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 24, 2026 | AwardD | 5,277 | 0.00 USD | — | SEC |
| Jun 24, 2026 | Award | 3,990 | 0.00 USD | — | SEC |
| Mar 16, 2026 | Exercise | 71,839 | — | — | SEC |
| Mar 16, 2026 | ExerciseD | -71,839 | 0.00 USD | $0 | SEC |
| Mar 12, 2026 | AwardD | 41,073 | 0.00 USD | $0 | SEC |
| Mar 12, 2026 | Award | 17,948 | 3.51 USD | $63K | SEC |
| Mar 12, 2026 | AwardD | 35,612 | 0.00 USD | $0 | SEC |
| Jan 13, 2026 | AwardD | 16,410 | 0.00 USD | $0 | SEC |
| Jan 6, 2026 | AwardD | 40,000 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | AwardD | 719,426 | 1.39 USD | $1M | SEC |
| Oct 30, 2025 | Award | 359,713 | 1.39 USD | $500K | SEC |
| Jun 24, 2025 | AwardD | 8,425 | 0.00 USD | $0 | SEC |
| Jun 24, 2025 | Award | 6,589 | 0.00 USD | $0 | SEC |
| Mar 17, 2025 | AwardD | 71,839 | 0.00 USD | $0 | SEC |
| Mar 17, 2025 | Exercise | 87,412 | — | — | SEC |
| Mar 17, 2025 | ExerciseD | -87,412 | 0.00 USD | $0 | SEC |
| Mar 17, 2025 | AwardD | 83,517 | 0.00 USD | $0 | SEC |
| Mar 17, 2025 | Award | 36,206 | 1.74 USD | $63K | SEC |
| Jan 7, 2025 | AwardD | 40,000 | 0.00 USD | $0 | SEC |
| Oct 11, 2024 | Award | 8,067 | — | — | SEC |
| Sep 5, 2024 | AwardD | 60,000 | 0.00 USD | $0 | SEC |
| Jun 25, 2024 | AwardD | 26,014 | 0.00 USD | $0 | SEC |
| Mar 18, 2024 | AwardD | 101,626 | 0.00 USD | $0 | SEC |
| Mar 18, 2024 | AwardD | 87,412 | 0.00 USD | $0 | SEC |
| Mar 18, 2024 | Award | 44,055 | 1.43 USD | $63K | SEC |